Reacción #8835

ord-6647c4f09b6c419a9d4dc6d55a619a4e

Ecuación de reacción

Brc1ccccc1
bromobezene
COc1cc2nc(Cl)[nH]c(=O)c2cc1OC
2-chloro-6,7-dimethoxy-3H-quinazolin-4-one
COc1cc2[nH]c(N3CCn4ccnc4C3)nc(=O)c2cc1OC
2-(5,6-dihydro-8H-imidazo[1,2-a]pyrazin-7-yl)-6,7-dimethoxy-1H-quinazolin-4-one
O=C([O-])[O-].[K+].[K+]
potassium carbonate
c1ccc(P(c2ccccc2)c2ccccc2)cc1
triphenylphosphine
c1cn2c(n1)CNCC2
5,6,7,8-Tetrahydro-imidazo[1,2-a]pyrazine
[NH4+].[OH-]
NH4OH
COc1cc2[nH]c(N3CCn4c(-c5ccccc5)cnc4C3)nc(=O)c2cc1OC
6,7-dimethoxy-2-(3-phenyl-5,6-dihydro-8H-imidazo[1,2-α]pyrazin-7-yl)-1H-quinazolin-4-one

Disolventes

Condiciones de reacción

Temperatura
140°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Concentraciónconcentrated onto silica gel
  2. 2
    Lavadoby eluting with 300:10:1 CH2Cl2

Procedimiento

5,6,7,8-Tetrahydro-imidazo[1,2-a]pyrazine, prepared as described in PCT Application WO 01/44250, was coupled with 2-chloro-6,7-dimethoxy-3H-quinazolin-4-one 1b, as described herein. 2-(5,6-dihydro-8H-imidazo[1,2-a]pyrazin-7-yl)-6,7-dimethoxy-1H-quinazolin-4-one (150 mg, 0.46 mmol) was combined with bromobezene (97 μL, 0.92 mmol), potassium carbonate (127 mg, 0.92 mmol), palladium acetate (5 mg, 5 mol %), and triphenylphosphine (13 mg, 10 mol %) in DMF (6 mL). The mixture was heated in a 140° C. bath for 2 d, then concentrated onto silica gel followed by eluting with 300:10:1 CH2Cl2:MeOH:NH4OH) to afford 50 mg of 6,7-dimethoxy-2-(3-phenyl-5,6-dihydro-8H-imidazo[1,2-α]pyrazin-7-yl)-1H-quinazolin-4-one, 904, mp: >300° C, M+=403.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07091200B2uspto-grants-2006_08